Aurinia Pharmaceuticals Inc.
$4.86
24H
Market Cap
Volume
Supply
Price Chart
About Aurinia Pharmaceuticals Inc. - AUPH
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations suffering from serious diseases with a high unmet medical need. Their most advanced drug candidate is voclosporin, used to treat conditions like lupus nephritis.
What are Aurinia Pharmaceuticals Inc.'s core values and mission statement?
Aurinia Pharmaceuticals Inc. is dedicated to delivering innovative solutions to improve the lives of patients with severe diseases. Their mission emphasizes a commitment to understanding the needs of patients and bringing forward transformative treatments.
Who founded Aurinia Pharmaceuticals Inc. and when?
Aurinia Pharmaceuticals Inc. was founded in 1993 by Robert Foster, Michael Martin, and Richard Glickman.
Who leads Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. is led by a management team, which, as of last available information, is headed by the CEO, Peter Greenleaf. The executive team's composition can be subject to change, so it's recommended to consult the company's official website or latest official releases for the most current leadership information.
Where is Aurinia Pharmaceuticals Inc. located, and what is its base country?
Aurinia Pharmaceuticals Inc. is headquartered in Victoria, British Columbia, Canada. Its base country is Canada.
On which exchanges is Aurinia Pharmaceuticals Inc. traded?
Aurinia Pharmaceuticals Inc. is traded on the NASDAQ under the ticker symbol AUPH and on the Toronto Stock Exchange (TSX) under the symbol AUP.
Historical data
Aurinia Pharmaceuticals Inc. (AUPH) Price Live Data
The live price of Aurinia Pharmaceuticals Inc. (AUPH) is $4.86, with a trading volume of 496,300 in the last 24 hours. Wrapstocks updates the AUPH price in real-time. Aurinia Pharmaceuticals Inc. is up 1.04% in the last 24 hours. The company has a live market cap of $702,843,520.00 and a supply of 144,618,008 AUPH stocks.
Aurinia Pharmaceuticals Inc. (AUPH) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 3 hours and 20 minutes.
